Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Monarch Pharmaceuticals Ireland Ltd

02 3Pfizer Inc

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

QUINUPRISTIN; DALFOPRISTIN

Brand Name : SYNERCID

Dosage Form : INJECTABLE; INJECTION

Dosage Strength : 500MG

Packaging :

Approval Date :

Application Number : 50747

Regulatory Info :

Registration Country : USA

blank

02

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

DALFOPRISTIN; QUINUPRISTIN

Brand Name : SYNERCID

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 350MG/VIAL;150MG/VIAL

Packaging :

Approval Date : 1999-09-21

Application Number : 50748

Regulatory Info : DISCN

Registration Country : USA

blank

03

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

DALFOPRISTIN; QUINUPRISTIN

Brand Name : SYNERCID

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 420MG/VIAL;180MG/VIAL

Packaging :

Approval Date : 2000-08-24

Application Number : 50748

Regulatory Info : DISCN

Registration Country : USA

blank

04

Monarch Pharmaceuticals Ireland Ltd

Country
The MedTech Conference
Not Confirmed
arrow

Monarch Pharmaceuticals Ireland Ltd

Country
arrow
The MedTech Conference
Not Confirmed

Dalfopristin; Quinupristin

Brand Name : Synercid

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength :

Packaging :

Approval Date : 25/02/2000

Application Number : 20000225000285

Regulatory Info : Deregistered

Registration Country : Sweden

blank